S‑Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope

• Padam Singh,
• Shashi Kant Kumar,
• Vineet Kumar Maurya,
• Basant Kumar Mehta,
• Hafsa Ahmad,
• Anil Kumar Dwivedi,
• Vinita Chaturvedi,
• Tejender S. Thakur,
• Sudhir Sinha

Affiliations

Padam Singh

†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India

Shashi Kant Kumar

†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India

Vineet Kumar Maurya

†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India

Basant Kumar Mehta

‡Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India

Hafsa Ahmad

§Division of Pharmaceutics, CSIR-Central Drug Research Institute, Lucknow, India

Anil Kumar Dwivedi

§Division of Pharmaceutics, CSIR-Central Drug Research Institute, Lucknow, India

Vinita Chaturvedi

†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India

Tejender S. Thakur

‡Division of Molecular and Structural Biology, CSIR-Central Drug Research Institute, Lucknow, India

Sudhir Sinha

†Division of Biochemistry, CSIR-Central Drug Research Institute, Lucknow, India